Newsfile Corp
03 Sept 2026, 02:01 UTC · 2w ago
Verdict
Headline leans bearish. We score CAPR −1.00 across three claims.
Score confirms the headline.
Leans bearish
From its wording — no explicit rating
−1.00strongly bearish
What the story claims
3 claims · scored −1 bearish … +1 bullish
Capricor Therapeutics is facing a class action lawsuit alleging it failed to disclose that the FDA had not agreed to changes in the statistical analysis plan for Deramiocel's clinical data.
More negative than 98% of claims this week
The lawsuit claims there is a substantial risk to the regulatory approval of Deramiocel for the treatment of Duchenne muscular dystrophy.
So whatFor biotech firms, the failure of a lead candidate's regulatory approval can lead to a catastrophic loss of valuation.
Continue reading
5 related stories
More negative than 96% of ticker scores this week
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
More negative than 96% of claims this week
A deadline of September 28, 2026, has been set for investors to move the Court to serve as lead plaintiff in the securities litigation.
More negative than 67% of claims this week
Which stocks this story touches
More negative than 96% of ticker scores this week
Facing a securities class action lawsuit alleging misleading statements regarding FDA clinical data and regulatory approval risks for Deramiocel.
More negative than 87% of ticker scores this week
Mentioned as being subject to a securities class action lawsuit.
More negative than 87% of ticker scores this week
Mentioned as being subject to a securities class action lawsuit.
More negative than 87% of ticker scores this week
Mentioned as being the subject of a securities class action investigation.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
GlobeNewsWire
7h ago
—
No price for CAPR right now — the quote feed didn't answer.
CAPR chart →
